When it comes to vaccines, where they go into your body can make a surprising difference in how well they work. Scientists in ...

To access our most recent research and articles on Covid-19 and Covid-19 vaccines, please visit the NEJM Coronavirus (Covid-19) page. To realize the potential of recently developed Covid-19 ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for ...

ASCO: new Sarclisa data support subcutaneous administration with on-body injector . New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via a ...

The three AGA mouse model groups were treated separately for 18 days as follows: Mock (subcutaneous injection, 0.1 mL/animal, every 3 days); murine EX104 (subcutaneous injection, 0.1 mL/animal, every ...

The first doses of an FDA-authorized Covid-19 vaccine have been delivered to all 50 states, the District of Columbia and Puerto Rico, a little after a year the disease was first discovered in China, ...

Representative high-resolution light microscopy images showing an array of empty bases pressed from polyanhydride polymer film and sealed microparticles. Scientists in the U.S. have developed ...

Scientists in the U.S. have developed polymer microparticles that can release vaccines at specific times after injection, sometimes even months later, potentially removing the need for multiple ...

AS04 significantly enhances the durability and efficacy of the immune response in HPV vaccines (141). Research has shown that when AS04 is used as an adjuvant, cytokines such as IL-6 and TNF-α are ...